Furthermore, TRIM21 level was low in diffuse large B-cell lymphoma and hepatocellular carcinoma and it negatively regulated the development of diffuse large B-cell lymphoma and hepatocellular carcinoma, and its lower expression could predict a shorter 5-year survival and overall survival [23, 24]. Here, TRIM21 is linked to diffuse large B-cell lymphoma.